CA2612989A1 - Osmotic dosage form - Google Patents

Osmotic dosage form Download PDF

Info

Publication number
CA2612989A1
CA2612989A1 CA002612989A CA2612989A CA2612989A1 CA 2612989 A1 CA2612989 A1 CA 2612989A1 CA 002612989 A CA002612989 A CA 002612989A CA 2612989 A CA2612989 A CA 2612989A CA 2612989 A1 CA2612989 A1 CA 2612989A1
Authority
CA
Canada
Prior art keywords
core
shell
dosage form
active ingredient
immediate release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002612989A
Other languages
English (en)
French (fr)
Inventor
Harry S. Sowden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2612989A1 publication Critical patent/CA2612989A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
CA002612989A 2006-05-08 2006-05-08 Osmotic dosage form Abandoned CA2612989A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/009202 WO2008105752A1 (en) 2006-05-08 2006-05-08 Osmotic dosage form

Publications (1)

Publication Number Publication Date
CA2612989A1 true CA2612989A1 (en) 2007-11-08

Family

ID=39595742

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002612989A Abandoned CA2612989A1 (en) 2006-05-08 2006-05-08 Osmotic dosage form

Country Status (4)

Country Link
EP (1) EP2007346A1 (de)
CN (1) CN101374497A (de)
CA (1) CA2612989A1 (de)
WO (1) WO2008105752A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3004070B1 (fr) * 2013-04-05 2015-07-31 Bel Fromageries Procede d'enrobage de produits fromagers
CN107576653B (zh) * 2017-06-24 2023-03-17 中瀚利加（北京）科技有限公司 一种用于鉴定孕妇羊水的组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
TW235239B (de) * 1992-11-20 1994-12-01 Pfizer
US6183466B1 (en) * 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
US6605302B2 (en) * 2001-07-17 2003-08-12 Osmotica Corp. Drug delivery device containing oseltamivir and an H1 antagonist
CA2499955A1 (en) * 2002-09-28 2004-04-08 Mcneil-Ppc, Inc. Delayed release dosage forms
MXPA06001506A (es) * 2003-08-04 2006-05-15 Pfizer Prod Inc Formas de dosificacion de inhibidores de la proteina de transferencia de colesteril ester e inhibidores de la hmg-coa reductasa.
WO2006082500A1 (en) * 2005-02-03 2006-08-10 Pfizer Products Inc. Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
US20060233882A1 (en) * 2005-04-15 2006-10-19 Sowden Harry S Osmotic dosage form
EP1749519A1 (de) * 2005-08-05 2007-02-07 Schering Aktiengesellschaft Arzneiform mit Retardtierter pH-unabhängiger Wirkstofffreisetzung für Wirkstoffe mit starker pH-abhängiger Löslichkeit

Also Published As

Publication number Publication date
CN101374497A (zh) 2009-02-25
EP2007346A1 (de) 2008-12-31
WO2008105752A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
US7416738B2 (en) Modified release dosage form
US8673352B2 (en) Modified release dosage form
EP1545472B1 (de) Darreichungsformen zur verzögerten freisetzung mit zwei kernen und einer öffnung
US20080206337A1 (en) Method of making dosage forms comprising polymeric compositions
CA2500311A1 (en) Modified release dosage forms
US20060233882A1 (en) Osmotic dosage form
CA2612989A1 (en) Osmotic dosage form
US20050196446A1 (en) Polymeric compositions and dosage forms comprising the same
US20050196447A1 (en) Polymeric compositions and dosage forms comprising the same
US20050196442A1 (en) Polymeric compositions and dosage forms comprising the same
CA2604158A1 (en) Modified release dosage form
WO2009023006A2 (en) Modified release dosage form
CA2556922C (en) Polymeric compositions and dosage forms comprising the same
KR20070017128A (ko) 중합체성 조성물 및 이를 포함하는 투여 형태
AU2002337772A1 (en) Modified release dosage forms
MXPA05003281A (es) Formas de dosis de liberacion modificada con dos nucleos y una abertura.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130508